Kriegsmann, Katharina
Ton, Gigi Nu Hoang Quy
Awwad, Mohamed H. S. https://orcid.org/0000-0003-4514-7199
Benner, Axel
Bertsch, Uta
Besemer, Britta
Hänel, Mathias
Fenk, Roland
Munder, Markus
Dürig, Jan
Blau, Igor W.
Huhn, Stefanie
Hose, Dirk
Jauch, Anna
Mann, Christoph
Weinhold, Niels https://orcid.org/0000-0002-5464-3234
Scheid, Christof
Schroers, Roland https://orcid.org/0000-0003-2744-5491
von Metzler, Ivana
Schieferdecker, Aneta
Thomalla, Jörg
Reimer, Peter
Mahlberg, Rolf
Graeven, Ullrich https://orcid.org/0000-0001-6082-7710
Kremers, Stephan
Martens, Uwe M.
Kunz, Christian
Hensel, Manfred
Seidel-Glätzer, Andrea
Weisel, Katja C. https://orcid.org/0000-0001-9422-6614
Salwender, Hans J. https://orcid.org/0000-0001-7803-0814
Müller-Tidow, Carsten https://orcid.org/0000-0002-7166-5232
Raab, Marc S. https://orcid.org/0000-0003-4181-6922
Goldschmidt, Hartmut
Mai, Elias K. https://orcid.org/0000-0002-6226-1252
Hundemer, Michael https://orcid.org/0000-0002-5596-2405
Funding for this research was provided by:
Bristol-Myers Squibb
Article History
Received: 1 December 2023
Revised: 6 May 2024
Accepted: 15 May 2024
First Online: 3 June 2024
Competing interests
: Katharina Kriegsmann: None. Gigi Nu Hoang Quy Ton: None. Mohamed H. S. Awwad: None. Axel Benner: None. Uta Bertsch: None. Britta Besemer: Honoraria Janssen Cilag, Sanofi, GSK. Mathias Hänel: Honoraria Novartis, SOBI, Gilead Sciences, Falk Foundation Consulting or Advisory Role Novartis, BMS/Celgene, Gilead Sciences, Pfizer, Incyte, Sanofi/Aventis, Roche, Amgen, SOBI, Janssen. Roland Fenk: Honoraria Amgen, BMS, GSK, Janssen, Sanofi, Takeda Travel grants BMS, Janssen, Sanofi. Markus Munder: Honoraria Janssen Oncology, BMS GmbH & Co KG, GlaxoSmithKline, Sanofi Consulting or Advisory Role Janssen Oncology, BMS GmbH & Co KG, GlaxoSmithKline, Sanofi, Takeda, Amgen, Stemline Therapeutics Travel, Accommodations, Expenses Amgen, Bristol Myers Squibb. Jan Dürig: Advisory Board Bristol-Myers Squibb, Celgene, Janssen Speakers bureau Celgene, Janssen. Igor W. Blau: None. Stefanie Huhn: None. Dirk Hose: None. Anna Jauch: None. Christoph Mann: Consulting or Advisory Role Sanofi, BMS, Janssen. Niels Weinhold: None. Christof Scheid: None. Roland Schroers: None. Ivana von Metzler: Honoraria Pfizer, Sanofi, BMS, GSK, Amgen, Janssen, Takeda, and AstraZeneca Consulting and Advisory Role Oncopeptides. Aneta Schieferdecker: None. Jörg Thomalla: None. Peter Reimer: Bristol Myers Squibb was one of several sponsors of continuing education at our clinic. Rolf Mahlberg: None. Ullrich Graeven: Stock and Other Ownership Interests Biontech Honoraria Boehringer Ingelheim Amgen, AstraZeneca, Bristol-Myers Squibb, MSD Oncology, Sanofi Aventis GmbH, Fujifilm, Novartis, Cellrion, Ipsen Consulting or Advisory Role Amgen, MSD Oncology Research Funding Ipsen, Macrogenics Travel, Accommodations, Expenses Boehringer Ingelheim GSK. Stephan Kremers: None. Uwe Martens: Consulting or Advisory Role Celgene, Sanofi-Aventis GmbH. Christian Kunz: Advisory Boards Amgen, BMS, Incyte, Roche, Novartis, Abbvie Travel, Accommodations, Expenses Beigene, Sanofi, Abbvie, BMS, Lilly. Manfred Hensel: None. Andrea Seidel-Glätzer: None. Katja C. Weisel: Honoraria Abbvie, Amgen, Adaptive Biotech, Astra Zeneca, BMS, BeiGene, Janssen, GSK, Karyopharm, Nobartis, Oncopeptides, Pfizer, Roche Pharma, Sanofi, Stemline, Takeda, Menarini Research grant Abbvie, Amgen, BMS, Janssen, GSK, Sanofi, Takeda Consulting or Advisory Role Abbvie, Amgen, Adaptive Biotech, BMS, BeiGene, Janssen, GSK, Karyopharm, Oncopeptides, Pfizer, Roche Pharma, Sanofi, Takeda, Menarini. Hans J. Salwender: Honoraria AbbVie, Amgen, AstraZeneca, BMS/Celgene, Genzyme, GSK, Janssen, Oncopeptides, Pfizer, Roche, Sanofi, Stemline, Takeda Travel Accommodations and Expenses Amgen, BMS/Celgene, Janssen, Sanofi. Carsten Müller-Tidow: None. Marc S. Raab: Consulting or Advisory Role BMS, Amgen, GSK, Janssen, Sanofi, Pfizer, AbbVie, Takeda Research Funding BMS, Janssen, Sanofi, Heidelberg Pharma Travel, Accomodations, Expenses BMS, Amgen, Janssen Honoraria BMS, Janssen, AbbVie, Sanofi. Hartmut Goldschmidt: Grants and/or provision of Investigational Medicinal Product Amgen, Array Biopharma/Pfizer, BMS/Celgene, Chugai, Dietmar-Hopp-Foundation, Janssen, Johns. Hopkins University, Mundipharma GmbH, Sanofi Research Funding Amgen, BMS, Celgene, GlycoMimetics Inc., GSK, Heidelberg Pharma, Hoffmann-La Roche, Karyopharm, Janssen, Incyte Corporation, Millenium Pharmaceuticals Inc., Molecular Partners, Merck Sharp and Dohme (MSD), MorphoSys AG, Pfizer, Sanofi, Takeda, Novartis Advisory Boards Amgen, BMS, Janssen, Sanofi, Adaptive Biotechnology Honoraria Amgen, BMS, Chugai, GlaxoSmithKline (GSK), Janssen, Novartis, Sanofi, Pfizer. Travel Accomodations, Expenses Amgen, BMS, GlaxoSmithKline (GSK), Janssen, Novartis, Sanofi, Pfizer. Elias K. Mai: Consulting or Advisory Role Bristol Myers Squibb/Celgene, GlaxoSmithKline, Janssen-Cilag, Sanofi Aventis, Stemline, Takeda; Honoraria Bristol Myers Squibb/Celgene, GlaxoSmithKline, Janssen-Cilag, Sanofi Aventis, Stemline, Takeda Research Funding Sanofi Aventis Travel Accommodations and Expenses Bristol Myers Squibb/Celgene, GlaxoSmithKline, Janssen-Cilag, Sanofi Aventis, Stemline, Takeda. Michael Hundemer: Consulting or Advisory Role Beigene, Becton Dickinson Research Funding Novartis, BeiGene, Sanofi Travel, Accomodations, Expenses BeiGene.